• Je něco špatně v tomto záznamu ?

Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries

J Kovacs, F Votava, G Heinze, J Solyom, J Lebl, Z Pribilincova, H Frisch, T Battelino, F Waldhauser, European Workshop on Paediatric Endocrinology-Congenital Adrenal Hyperplasia Study Group Middle

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13025854

Grantová podpora
NE6133 MZ0 CEP - Centrální evidence projektů

Despite the fact that congenital adrenal hyperplasia (CAH) is one of the most common inborn endocrine disorders, some patients are not identified, or may even die, in an acute salt-losing crisis. In a retrospective study covering the last 30 yr, we examined the time elapsing before diagnosis of CAH patients, in 5 Middle European countries, and the mortality rate in diagnosed patients and their siblings during childhood; we also attempted to estimate how many patients are not diagnosed clinically each year. Basic and follow-up clinical data and the family histories of 484 patients with classical forms of CAH diagnosed between 1969 and 1998 were collected and recorded in 5 Middle European countries. The sex-ratio, time elapsing before diagnosis, and mortality among siblings and patients were calculated, and the number of undiagnosed patients was estimated. We found significantly fewer genetic males (43.0%) than females (57.0%) among 484 classic CAH patients, and the percentage of diagnosed boys did not increase with time; 64.7% of them suffered from the salt-wasting (SW) form, and 35.3% from the simple virilizing (SV) form, of the disease. The diagnosis of CAH was established significantly later in males than in females in both forms [SW: 26 vs. 13 days (median), P < 0.0001; SV: 5.0 vs. 2.8 yr, P = 0.03]. Infant mortality in the general population was significantly lower than in either siblings (1.8% vs. 7.0%; P < 0.0001) or in SW (2.29% vs. 11.3%; P < 0.0001). According to our calculations, by our current praxis of clinical ascertainment, 2-2.5 SW and up to 5 SV stay undiagnosed, out of 40 expected CAH patients per year in the countries investigated. Both clinical detection and treatment of CAH patients, at least in males, were insufficient in the five Middle European countries examined during the last 30 yr. Neonatal mass screening and/or greater awareness of the medical community are discussed as ways of improving the efficacy of CAH management. Our experience may be applicable to other countries with similar health care systems.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc13025854
003      
CZ-PrNML
005      
20130902161522.0
007      
ta
008      
130726s2001 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1210/jcem.86.7.7638 $2 doi
035    __
$a (PubMed)11443151
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kovacs J $u Department of Pediatrics, University of Vienna, A-1090 Vienna, Austria.
245    10
$a Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries / $c J Kovacs, F Votava, G Heinze, J Solyom, J Lebl, Z Pribilincova, H Frisch, T Battelino, F Waldhauser, European Workshop on Paediatric Endocrinology-Congenital Adrenal Hyperplasia Study Group Middle
504    __
$a Literatura
520    9_
$a Despite the fact that congenital adrenal hyperplasia (CAH) is one of the most common inborn endocrine disorders, some patients are not identified, or may even die, in an acute salt-losing crisis. In a retrospective study covering the last 30 yr, we examined the time elapsing before diagnosis of CAH patients, in 5 Middle European countries, and the mortality rate in diagnosed patients and their siblings during childhood; we also attempted to estimate how many patients are not diagnosed clinically each year. Basic and follow-up clinical data and the family histories of 484 patients with classical forms of CAH diagnosed between 1969 and 1998 were collected and recorded in 5 Middle European countries. The sex-ratio, time elapsing before diagnosis, and mortality among siblings and patients were calculated, and the number of undiagnosed patients was estimated. We found significantly fewer genetic males (43.0%) than females (57.0%) among 484 classic CAH patients, and the percentage of diagnosed boys did not increase with time; 64.7% of them suffered from the salt-wasting (SW) form, and 35.3% from the simple virilizing (SV) form, of the disease. The diagnosis of CAH was established significantly later in males than in females in both forms [SW: 26 vs. 13 days (median), P < 0.0001; SV: 5.0 vs. 2.8 yr, P = 0.03]. Infant mortality in the general population was significantly lower than in either siblings (1.8% vs. 7.0%; P < 0.0001) or in SW (2.29% vs. 11.3%; P < 0.0001). According to our calculations, by our current praxis of clinical ascertainment, 2-2.5 SW and up to 5 SV stay undiagnosed, out of 40 expected CAH patients per year in the countries investigated. Both clinical detection and treatment of CAH patients, at least in males, were insufficient in the five Middle European countries examined during the last 30 yr. Neonatal mass screening and/or greater awareness of the medical community are discussed as ways of improving the efficacy of CAH management. Our experience may be applicable to other countries with similar health care systems.
590    __
$a bohemika - dle Pubmed
650    12
$a kongenitální adrenální hyperplazie $x diagnóza $x epidemiologie $x genetika $x terapie $7 D000312
650    02
$a ženské pohlaví $7 D005260
650    02
$a lidé $7 D006801
650    02
$a mužské pohlaví $7 D008297
650    02
$a retrospektivní studie $7 D012189
650    02
$a pohlavní dimorfismus $7 D012727
650    02
$a míra přežití $7 D015996
650    02
$a časové faktory $7 D013997
651    _2
$a Rakousko $x epidemiologie $7 D001317
651    _2
$a Česká republika $x epidemiologie $7 D018153
651    _2
$a Maďarsko $x epidemiologie $7 D006814
651    _2
$a Slovenská republika $x epidemiologie $7 D018154
651    _2
$a Slovinsko $x epidemiologie $7 D017524
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Votava, Felix, $d 1957- $7 xx0060357
700    1_
$a Heinze G
700    1_
$a Solyom J
700    1_
$a Lebl, Jan, $d 1955- $7 jn19990010093
700    1_
$a Pribilincová, Zuzana $7 xx0073901
700    1_
$a Frisch H
700    1_
$a Battelino T
700    1_
$a Waldhauser F
700    1_
$a Middle European Workshop on Paediatric Endocrinology-Congenital Adrenal Hyperplasia Study Group
773    0_
$t Journal of Clinical Endocrinology & Metabolism $x 0021-972X $g Roč. 86, č. 7 (2001), s. 2958-2964 $p J Clin Endocrinol Metab $w MED00002582
773    0_
$p J Clin Endocrinol Metab $g 86(7):2958-64, 2001 Jul $x 0021-972X
910    __
$a ABA008 $y 3 $z 0
990    __
$a 20130726122432 $b ABA008
991    __
$a 20130902162009 $b ABA008
999    __
$a ok $b bmc $g 989649 $s 824258
BAS    __
$a 3
BMC    __
$a 2001 $b 86 $c 7 $d 2958-2964 $i 0021-972X $m The Journal of clinical endocrinology and metabolism $x MED00002582
GRA    __
$a NE6133 $p MZ0
LZP    __
$c NLK115 $d 20130902 $a 2013-07/ew

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...